|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.105 USD | -3.91% |
|
+0.93% | +98.18% |
| 05-14 | Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
Xilio Therapeutics, Inc. announced that Dave Gardner of Rock Springs Capital and Andrew Hack, M.D., Ph.D, of Bain Capital Life Sciences will join the Xilio Therapeutics Board of Directors.
| 1st Jan change | Capi. | |
|---|---|---|
| +98.18% | 42.44M | |
| +63.66% | 62.59B | |
| -1.76% | 41.18B | |
| +44.76% | 40.29B | |
| -8.93% | 27.9B | |
| +12.75% | 26.21B | |
| -21.69% | 19.09B | |
| +4.25% | 13.08B | |
| +25.60% | 12.26B | |
| +28.31% | 12.05B |
XILIO THERAPEUTICS, INC. 
